PathCentral Receives $10,000,000 Series B Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1144f34f-f33a-4f97-af3a-c6abd98a62e1&Preview=1 -
Date
11/2/2010 -
Company Name
PathCentral -
Mailing Address
213 Technology Dr. Irvine, CA 92629 -
Company Description
PathCentral is the first and only company to provide all the tools required by community pathology practices to increase revenues, improve operating efficiencies, and ensure patient safety, in a single integrated and affordable platform. -
Website
http://www.pathcentral.net -
Transaction Type
Venture Equity -
Transaction Amount
$10,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The proceeds will be used to support the company’s growth initiatives, continue to enhance its web-based laboratory information system (LIS), deploy a field sales force, and build out its esoteric cancer diagnostics laboratory. -
M&A Terms
-
Venture Investor
Okapi Venture Partners -
Venture Investor
Arboretum Ventures -
Venture Investor
Baird Venture Partners
